Indicator of access to medicines in relation to the multiple dimensions of access-Reference-Cited by-同舟云学术

Indicator of access to medicines in relation to the multiple dimensions of access

Published:2019-09 Issue:12 Volume:8 Page:1027-1041
ISSN:2042-6305
Container-title:Journal of Comparative Effectiveness Research
language:en
Short-container-title:Journal of Comparative Effectiveness Research

Author:

Garcia Marina M¹,Barbosa Mariana M¹,Silva Rondineli M²,Reis Edna A³,Alvares Juliana¹,Assis Acurcio Francisco de¹,Godman Brian⁴⁵⁶⁷,Guerra Junior Augusto A¹

Affiliation:

1. Federal University of Minas Gerais, Department of Social Pharmacy, Av. Presidente Antônio Carlos, 6627, Belo Horizonte, Minas Gerais, 31270-901, Brazil

2. Sérgio Arouca National School of Public Health of the Oswaldo Cruz Foundation, Department of Drug Policy and Pharmaceutical Assistance, St Leopoldo Bulhões, Room 622–632, Rio de Janeiro, 21041-210, Brazil

3. Federal University of Minas Gerais, Department Institute of Exact Sciences, Av. Presidente Antônio Carlos, 6627, Belo Horizonte, Minas Gerais, 31270-901, Brazil

4. Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, G4 0RE, UK

5. Health Economics Centre, University of Liverpool Management School, Liverpool, UK

6. Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, SE-141 86, Stockholm, Sweden

7. School of Pharmacy, Sefako Makgatho Health Sciences University, Ga-Rankuwa, Gauteng, South Africa

Abstract

Aim: Creation of a single indicator of access to medicines. Methods: Data collection was performed with individuals who obtained their medication from either public and/or private pharmacies. A Likert scale was used to measure the importance and satisfaction in relation to various access dimensions. Results: A total of 580 individuals were interviewed. Overall, participants attributed very similar importance scores to the dimensions of access to medicines. The results of the mean score of each dimension showed a statistically significant difference according to the type of pharmacy that the participant visited. Conclusion: This developed indicator will enable a review of access to medicines, making comparisons possible as well as improving decision making about public policies in the field of Pharmaceutical Services.

Publisher

Future Medicine Ltd

Subject

Health Policy

Link

https://www.futuremedicine.com/doi/pdf/10.2217/cer-2019-0031

Reference79 articles.

1. Hogerzeil HV , Mirza Z . The World Medicines Situation Report, 2011. WHO, Switzerland (2011). http://apps.who.int/medicinedocs/documents/s20054en/s20054en.pdf?ua=1

2. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis

3. Irrational Use of Medicines—A Summary of Key Concepts

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disponibilidad y distribución de los recursos de hemostasia y trombosis en Argentina en el año 2022;Revista Hematología;2024-04-30

2. Perceptions of and Preparedness for the Application of Pharmacoeconomics in Practice, among Final Year Bachelor of Pharmacy Students in South Africa: A National Cross-Sectional Study;Pharmacy;2023-03-14

3. Knowledge, attitudes and practices of healthcare professionals on the use of an electronic stock visibility and management tool in a middle-income country: Implications for access to medicines;Exploratory Research in Clinical and Social Pharmacy;2023-03

4. Access to medicines in the Brazilian Unified Health System’s primary health care: assessment of a public policy;Journal of Comparative Effectiveness Research;2021-07

5. Perceptions, Expectations, and Experience of Physicians About Pharmacists and Pharmaceutical Care Services in Pakistan: Findings and Implications;Frontiers in Pharmacology;2021-05-14